METAGLIP Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Metaglip, and when can generic versions of Metaglip launch?
Metaglip is a drug marketed by Bristol Myers Squibb and is included in one NDA.
The generic ingredient in METAGLIP is glipizide; metformin hydrochloride. There are eighteen drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the glipizide; metformin hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Metaglip
A generic version of METAGLIP was approved as glipizide; metformin hydrochloride by EPIC PHARMA LLC on October 27th, 2005.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for METAGLIP?
- What are the global sales for METAGLIP?
- What is Average Wholesale Price for METAGLIP?
Summary for METAGLIP
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 4 |
| Clinical Trials: | 4 |
| Drug Prices: | Drug price information for METAGLIP |
| DailyMed Link: | METAGLIP at DailyMed |
Recent Clinical Trials for METAGLIP
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Mylan Pharmaceuticals | Phase 1 |
| Teva Pharmaceuticals USA | Phase 1 |
US Patents and Regulatory Information for METAGLIP
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bristol Myers Squibb | METAGLIP | glipizide; metformin hydrochloride | TABLET;ORAL | 021460-001 | Oct 21, 2002 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Bristol Myers Squibb | METAGLIP | glipizide; metformin hydrochloride | TABLET;ORAL | 021460-002 | Oct 21, 2002 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Bristol Myers Squibb | METAGLIP | glipizide; metformin hydrochloride | TABLET;ORAL | 021460-003 | Oct 21, 2002 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
